Company news
IDT Australia Limited news
Latest news releases, newest first. Pick a year for every news release, call and deck from that year.
Update - Response to FDA Warning Letter
June 7, 2018
IDT receives FDA Warning Letter
May 28, 2018
Divestment of Selected Generic Product Portfolio
April 3, 2018
Replacement Appendix 4D
February 26, 2018
Strategic and Operational Review Update
February 25, 2018
Appointment interim Chief Executive Officer
February 15, 2018
IDT Executes API Development Agreement
November 8, 2017
CMAX transaction completed
August 23, 2017
Appendix 4G
August 22, 2017
Annual Report to shareholders
August 22, 2017
IDT Australia: Updated Charter Remuneration and Nomination Committee
August 22, 2017
IDT Australia: Updated Charter Audit and Risk Committee
August 22, 2017
Resignation of Managing Director
July 14, 2017
Director Retirement - Graeme Blackman
June 12, 2017
Corporate Governance Statement
June 8, 2017
US launch of Pindolol
May 8, 2017
FDA review clears Pindolol for US launch
April 27, 2017
Appendix 3Z
April 26, 2017
Generics Sales Update
April 11, 2017
Completion of Initial CMAX Transaction
December 15, 2016
Mayne Pharma Announces U.S. Launch of IDTs Temozolomide
November 21, 2016
IDT: 1st generic proprietary prod shipped to US, temozolomide
November 1, 2016
IDT Divests CMAX Clinical Trial Business to Irom Group
October 27, 2016
Trading halt
October 26, 2016
Cancellation of shares
September 21, 2016
Awarded Future Industries Manufacturing Program Grant
September 6, 2016
Completion of private placement
June 29, 2016
CMAX - Opening of new Clinical Trial Facility
May 2, 2016
FDA Approval for Temozolomide
April 13, 2016
Reinstatement to Official Quotation
March 30, 2016
Manufacturing partner appointed
March 29, 2016
Thiotepa - Contract Extension and Revenues
March 8, 2016
$6m Placement to Accelerate IDTs Generic Drug Portfolio
February 11, 2016
IDT Executes US Distribution Agreement for Temozolomide
February 10, 2016
Decks
The 5 newest of 33 decks. Every deck is listed under its year.
- FY2026 Earnings Presentation
Earnings · 12 slides · Aug 20, 2026
- H1 FY2026 Earnings Presentation
Earnings · 12 slides · Feb 18, 2026
- Shareholder Meeting (November 2025)
Shareholder meeting · 11 slides · Nov 19, 2025
- H1 2025 Earnings Presentation
Earnings · 18 slides · Feb 25, 2025
- Shareholder Meeting (November 2024)
Shareholder meeting · 14 slides · Nov 19, 2024